Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis

This study has been completed.
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00728598
First received: August 1, 2008
Last updated: August 5, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 1998
  Primary Completion Date: December 1998 (Final data collection date for primary outcome measure)